Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
AbstractIon homeostasis is extremely important for the survival of both normal as well as neoplastic cells. The altered ion homeostasis found in cancer cells prompted the investigation of several ionophores as potential anticancer agents. Few ionophores, such as Salinomycin, Nigericin and Obatoclax, have demonstrated potent anticancer activities against cancer stem-like cells that are considered highly resistant to chemotherapy and responsible for tumor relapse. The preclinical success of these compounds in in vitro and in vivo models have not been translated into clinical trials. At present, phase I/II clinical trials demonstrated limited benefit of Obatoclax alone or in combination with other anticancer drugs. However, future development in targeted drug delivery may be useful to improve the efficacy of these compounds. Alternatively, these compounds may be used as leading molecules for the development of less toxic derivatives. View Full-Text
Share & Cite This Article
Kaushik, V.; Yakisich, J.S.; Kumar, A.; Azad, N.; Iyer, A.K.V. Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers. Cancers 2018, 10, 360.
Kaushik V, Yakisich JS, Kumar A, Azad N, Iyer AKV. Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers. Cancers. 2018; 10(10):360.Chicago/Turabian Style
Kaushik, Vivek; Yakisich, Juan S.; Kumar, Anil; Azad, Neelam; Iyer, Anand K.V. 2018. "Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers." Cancers 10, no. 10: 360.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.